search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    bluebird bio, Inc.

    (NASDAQ:BLUE)

    $4.28

    $0.14

    3.38%

    bluebird bio, Inc. Chart

    BLUE Stock Price Today

    bluebird bio, Inc. (BLUE) stock rallied over 3.38% intraday to trade at $4.28 a share on NASDAQ. The stock opened with a loss of -4.04% at $4.14 and touched an intraday high of $4.33, rising 3.38% against the last close of $4.14. The stock went to a low of $4.07 during the session.

    Stock Snapshot

    $4.14

    Prev. Close

    295.79 Million

    Market Cap

    $4.07

    Day Low

    $4.14

    Open

    73.69 Million

    Number of Shares

    $4.33

    Day High

    -

    P/E ratio

    -8.01

    EPS (TTM)

    4.19

    Cash Flow per Share

    24.81

    Free Float in %

    12.42

    Book Value

    3,986,981

    Volume

    bluebird bio, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$4.14$4.33$4.07$4.283,995,500
    2022-06-30$4.46$4.54$4.12$4.146,418,700
    2022-06-29$4.01$4.66$3.89$4.5812,419,200
    2022-06-28$4.23$4.23$3.9$4.047,730,000
    2022-06-27$4.39$4.4$4.07$4.295,323,800
    2022-06-24$4.25$4.49$4.02$4.47,703,200
    2022-06-23$4$4.29$3.8$4.2811,094,500
    2022-06-22$4.03$4.72$3.91$4.4615,190,100
    2022-06-21$3.66$4.4$3.55$4.1620,914,900
    2022-06-17$3.24$4.29$3.16$3.5663,659,600

    Contact Details

    60 Binney Street
    Cambridge, MA 02142
    United States

    Webiste:BLUE

    339 499 9300

    Company Information

    Employees-

    Beta1.35

    Sales or Revenue3.66 Million

    5Y Sales Change-9.90%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current bluebird bio, Inc. (BLUE) stock price?

    bluebird bio, Inc. (NASDAQ: BLUE) stock price is $4.28 as of the last check on Friday, July 1. During the trading session, BLUE stock reached the peak price of $4.33 while $4.07 was the lowest point it dropped to.

    icon

    BLUE's industry and sector of operation?

    The NASDAQ listed BLUE is part of Biotechnology industry that operates in the broader Health Care sector. bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases.

    icon

    Who are the executives of BLUE?

    Mr. Nick Leschly
    Pres & Director
    Mr. William D. Baird III
    Principal Financial & Accounting Officer
    Mr. Andrew Obenshain
    CEO & Director
    Ms. Gina R. Consylman CPA
    Chief Financial Officer

    icon

    What is the BLUE stock price today?

    BLUE stock traded closed the last session at $4.28, which is $0.14 or 3.38% lower than its previous close of $4.14. BLUE's current trading price is 49.39% lower than its 52-week high of $21.16 where as its distance from 52-week low of 2.87% is -79.77%.

    icon

    How many employees does BLUE have?

    Number of BLUE employees currently stands at -. BLUE operates from 60 Binney Street, Cambridge, MA 02142, United States.

    icon

    Link for BLUE official website?

    Official Webiste of $BLUE is: https://www.bluebirdbio.com

    icon

    How do I contact BLUE?

    BLUE could be contacted at BLUE operates from 60 Binney Street, Cambridge, MA 02142, United States, or at phone #339 499 9300 and can also be accessed through its website.

    icon

    How many shares of BLUE are traded daily?

    BLUE stock volume for the day was 3,986,981 shares while in the previous session number of BLUE shares traded was 3,995,500 . The average number of BLUE shares traded daily for last 3 months was 6.11 Million.

    icon

    How much did BLUE change today?

    The percentage change in BLUE stock occurred in the recent session was 3.38% while the dollar amount for the price change in BLUE stock was $0.14.

    icon

    What price range BLUE stock been trading in?

    In the recent session, the day high for BLUE stock was $4.33 while the low for BLUE stock touched on the day was $4.07.

    icon

    What is the market cap of BLUE currently?

    The market value of BLUE currently stands at 295.79 Million with its latest stock price at $4.28 and 73.69 Million of its shares outstanding.